KALAKALA BIO, Inc.
0.8201USD-8.88%Mkt Cap: 15.86M $P/E: —3d ago
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company dev…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap15.86M $
Enterprise Value7.97M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.98M $
Revenue/Share—
Last Price0.8201 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4831192020
Valuation
P/E (Trailing)—
P/E (Forward)-0.13
PEG—
EV/EBITDA-0.24
EV/Revenue—
P/S—
P/B1.45
EPS (TTM)-8.62
EPS (Forward)-6.67
52W Range
0.59000% of range1030.00
52W High1030.00 USD
52W Low0.5900 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-385.65%
ROA-284.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.99M $
CapEx (TTM)15.00K $
FCF Margin—
FCF Yield-130.15%
Net Debt-8.76M $
Net Debt/EBITDA0.26
Balance Sheet
Debt/Equity0.00
Current Ratio7.91
Quick Ratio5.68
Book Value/Sh0.5790 USD
Cash/Share0.4710 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 11, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.19.34M
Float18.59M
Insiders1.24%
Institutions3.61%
Short Interest
Short Ratio1.6d
Short % Float1.45%
Short % Out.1.44%
Shares Short279.43K
Short (prev mo.)218.55K
Technical
SMA 501.440 (-43.0%)
SMA 20015.57 (-94.7%)
Beta-2.28
S&P 52W Chg18.16%
Avg Vol (30d)117.74K
Avg Vol (10d)70.22K
Technical Indicators
RSI (14)37.9
MACD-0.1462
MACD Signal-0.2263
MACD Hist.+0.0801
BB Upper0.9749 USD
BB Middle0.7715 USD
BB Lower0.5680 USD
BB Width52.75%
ATR (14)0.1372 USD
Vol Ratio (20d)1.22x